Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer.

Okumura, Shunsuke; Sasaki, Takaaki; Satoh, Kazuhiro; Kitada, Masahiro; Nagase, Atsushi; Yatsuyanagi, Eiji; Ohsaki, Yoshinobu

Okumura, Shunsuke; Sasaki, Takaaki; Satoh, Kazuhiro; Kitada, Masahiro; Nagase, Atsushi; Yatsuyanagi, Eiji; Ohsaki, Yoshinobu.

Afiliação

Okumura S; Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 0788510;
Sasaki T; Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 0788510;
Satoh K; Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 0788510;
Kitada M; Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 0788510;
Nagase A; Department of Respiratory Surgery, National Hospital Organization, Asahikawa Medical Center, Asahikawa, Hokkaido 0708644;
Yatsuyanagi E; Department of Respiratory Surgery, National Hospital Organization, Obihiro Hospital, Obihiro, Hokkaido 0808518, Japan.
Ohsaki Y; Respiratory Center, Asahikawa Medical University, Asahikawa, Hokkaido 0788510;

Mol Clin Oncol ; 1(1): 124-130, 2013 Jan.

Article em En | MEDLINE | ID: mdl-24649134